Fidelity data show that when semiconductor EPS growth exceeds price returns, the sector gains with near 100% probability over 12 months, and the current relative P/E at the bottom 25% supports a 77% probability of outperforming the market.
Fidelity's semiconductor report argues EPS growth is exceeding share-price gains, historically giving near 100% odds of semiconductor gains over the next 12 months; semis also trade near the bottom quartile of relative PER with 77% probability of outperforming. Because Korean and US semis are linked, Samsung Electronics and SK hynix should outperform into year-end/next year, with buybacks sealing the downside.
Korean cosmetics exports grew 37.8% in July and 52% in August, and have been positive for nine consecutive months. Korean Kolmar, a representative cosmetics name, saw institutions accumulate over 600,000 shares from July and foreign buying before reporting 50% operating profit growth and 68% net profit growth, driving a sharp rally; the export trend supports continued strength.
Own earnings-upgraded laggards with institutional inflows.
Screening for market cap above 1 trillion won, forward earnings upgrades, not having already surged relative to the market, and healthy foreign/institutional inflows identifies LG Energy Solution, LS, Yuhan, Daeduk Electronics, and TES. These are mostly secondary battery, bio, and semiconductor equipment/materials laggards that could pay off later in Q4 once foreign selling abates after the September FOMC.
Biohealth exports rose 30.4% in July and stayed strong in August. Celltrion is a large-cap biotech that began rising from August 1 with institutional and foreign accumulation; the data supports biohealth as an alternative export theme to semiconductors.
Fidelity's semiconductor report argues EPS growth is exceeding share-price gains, historically giving near 100% odds of semiconductor gains over the next 12 months; semis also trade near the bottom quartile of relative PER with 77% probability of outperforming. Because Korean and US semis are linked, Samsung Electronics and SK hynix should outperform into year-end/next year, with buybacks sealing the downside.
Own earnings-upgraded laggards with institutional inflows.
Screening for market cap above 1 trillion won, forward earnings upgrades, not having already surged relative to the market, and healthy foreign/institutional inflows identifies LG Energy Solution, LS, Yuhan, Daeduk Electronics, and TES. These are mostly secondary battery, bio, and semiconductor equipment/materials laggards that could pay off later in Q4 once foreign selling abates after the September FOMC.
Own earnings-upgraded laggards with institutional inflows.
Screening for market cap above 1 trillion won, forward earnings upgrades, not having already surged relative to the market, and healthy foreign/institutional inflows identifies LG Energy Solution, LS, Yuhan, Daeduk Electronics, and TES. These are mostly secondary battery, bio, and semiconductor equipment/materials laggards that could pay off later in Q4 once foreign selling abates after the September FOMC.
Own earnings-upgraded laggards with institutional inflows.
Screening for market cap above 1 trillion won, forward earnings upgrades, not having already surged relative to the market, and healthy foreign/institutional inflows identifies LG Energy Solution, LS, Yuhan, Daeduk Electronics, and TES. These are mostly secondary battery, bio, and semiconductor equipment/materials laggards that could pay off later in Q4 once foreign selling abates after the September FOMC.
Private funds bought Samsung Electronics preferred shares rather than common during August. The common/preferred discount widened from a typical 25% to over 50% after June, and funds appear positioned for that gap to narrow, making the preferred a cheaper path to Samsung exposure with discount-narrowing upside.